US EditionPublished • loading... • Updated
Lucida Medical raises $11.4m to advance AI prostate cancer diagnostic
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lucida Medical raises $11.4m to advance AI prostate cancer diagnostic
Lucida’s software is designed to identify prostate cancer ‘within minutes’ and overcome diagnosis delays associated with worse patient outcomes.The post Lucida Medical raises $11.4m to advance AI prostate cancer diagnostic appeared first on Medical Device Network.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
